Tudor I. Oprea - Concepedia

Author

Tudor I. Oprea

Also Known As

Consortium, The IDG-DREAM Drug-Kinase Binding Prediction Challenge, Gábor Turu, Leitão, Andrei, Oprea, T., Oprea, Teodor, Oprea, Tudor, Oprea, Tudor I., Oprea, Tudor I, Oprea, Tudor I., T I Oprea

509

Publications

28.4K

Citations

H-Index

252

Concepts

All Affiliations

University of New Mexico Biocom New Mexico Cancer Center University of Copenhagen University of Gothenburg

About

Tudor I. Oprea is an author at University of New Mexico specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	51	90	10.4K
2	Engineering	22	30	3K
3	Natural Sciences	22	28	2.6K
4	Health Sciences	3	3	566
5	Management	1	1	46

Tudor I. Oprea

172

Publications

17.9K

Citations

H-Index

Page 1

	Year	Citations
Virtual and biomolecular screening converge on a selective agonist for GPR30 Cristian Bologa, Chetana M. Revankar, Susan Young, Nature Chemical Biology Drug TargetG Protein-coupled ReceptorMedicineFunctional SelectivityPharmacology	2006	805
The Design of Leadlike Combinatorial Libraries Simon J. Teague, A. M. Davis, Paul D. Leeson, Angewandte Chemie International Edition Pharmaceutical ResearchHit IdentificationAffinity EnhancementLeadlike Combinatorial LibrariesMolecular Pharmacology	1999	801
Is There a Difference between Leads and Drugs? A Historical Perspective Tudor I. Oprea, A. M. Davis, Simon J. Teague, Journal of Chemical Information and Computer Sciences	2001	771
Property distribution of drug-related chemical databases* Tudor I. Oprea Journal of Computer-Aided Molecular Design	2000	618
BDDCS Applied to Over 900 Drugs Leslie Z. Benet, Fabio Broccatelli, Tudor I. Oprea The AAPS Journal MedicineBddcs AppliedPharmacotherapyDrug DevelopmentPharmacology	2011	613
In vivo effects of a GPR30 antagonist Megan K. Dennis, Ritwik Burai, Chinnasamy Ramesh, Nature Chemical Biology Functional SelectivityMedicinePharmacological AgentNeuropharmacologyExperimental Pharmacology	2009	514
Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system Eugen Brailoiu, Siok L. Dun, G. Cristina Brailoiu, Journal of Endocrinology	2007	496
Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients Anders Boeck Jensen, Pope Moseley, Tudor I. Oprea, Nature Communications	2014	411
G Protein–Coupled Receptor 30 (GPR30) Mediates Gene Expression Changes and Growth Response to 17β-Estradiol and Selective GPR30 Ligand G-1 in Ovarian Cancer Cells Lidia Albanito, Antonio Madeo, Rosamaria Lappano, Cancer Research	2007	390
Drug repurposing from an academic perspective Tudor I. Oprea, Julie E. Bauman, Cristian Bologa, Drug Discovery Today Therapeutic Strategies Academic PerspectiveSubstance AbuseDrug RepositioningAddictionPrescription Drugs	2011	363

Page 1